Aptar enters into agreement with weihai hengyu medical products to add elastomeric and plastic component manufacturing capabilities in china for injectable drug delivery

Crystal lake, ill.--(business wire)--aptargroup, inc. (nyse: atr), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced today that it has entered into an agreement to acquire 80% of the equity interests of weihai hengyu medical products co., ltd., a leading chinese manufacturer of elastomeric and plastic components used in injectable drug delivery. this acquisition supports aptar's strategic priority to strengthen capabilities in high-gro
ATR Ratings Summary
ATR Quant Ranking